Clinical trials

ClinicalTrials.gov record NCT06455059↗

PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was vosoritide.↗

Source record context

What this record can answer

This page can answer what the retained ClinicalTrials.gov observation for NCT06455059 records: the status, phases, conditions and interventions shown at that observation. It does not provide or establish participant outcomes, safety, effectiveness, approval or a recommendation to use an intervention.

ClinicalTrials.gov record NCT06455059 · Open source record ↗

Continue with profile context

These profile links provide broader, bounded context while keeping this source record’s identity and version separate.

Update · November 15, 2026

ClinicalTrials.gov posted a newer version of NCT06455059, with a registry update date of 2026-11-12. This version reports that observation; the earlier retained observation remains available as version 1. 1

This version supersedes public version 1.

PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was vosoritide. 1

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1

Complete submitted registry timeline

4 ClinicalTrials.gov record-history versions

Explore all trial histories →

ClinicalTrials.gov lists these public versions with submitted dates from June 7, 2024 through January 15, 2026. Each entry links to the exact public source version and reports only the source-declared status, study type, dates, and changed-module labels.

  1. NCT06455059 · history version 1

    June 7, 2024

    Open exact source version ↗
    Registry status
    Enrolling By Invitation
    Study type
    interventional
    Last submitted QC date
    June 7, 2024

    Source-declared changed modules: None listed for this version

  2. NCT06455059 · history version 2

    March 17, 2025

    Open exact source version ↗
    Registry status
    Enrolling By Invitation
    Study type
    interventional
    Last submitted QC date
    March 17, 2025

    Source-declared changed modules: Contacts/Locations, Oversight, Study Identification, Study Status

  3. NCT06455059 · history version 3

    October 9, 2025

    Open exact source version ↗
    Registry status
    Active Not Recruiting
    Study type
    interventional
    Last submitted QC date
    October 9, 2025

    Source-declared changed modules: Study Identification, Study Status

  4. NCT06455059 · history version 4

    January 15, 2026

    Open exact source version ↗
    Registry status
    Active Not Recruiting
    Study type
    interventional
    Last submitted QC date
    January 15, 2026

    Source-declared changed modules: Oversight, Study Status

Sources and evidence

  1. 1

Preserved public versions

Earlier versions of this record

Every earlier public version is kept here with its original wording and sources. The current version above supersedes them.

Superseded public version 1

Version 1: ClinicalTrials.gov record NCT06455059↗

PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-20, and PeptideScanner's reviewed identity mapping was vosoritide.↗

PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-20, and PeptideScanner's reviewed identity mapping was vosoritide. 1

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1

Sources for version 1

  1. 1